老年医保患者中电休克治疗与全因死亡及自杀风险的关联
该观察性研究纳入65岁及以上接受医保的精神科住院患者,将接受电休克治疗(ECT)者与对照组按1:3精确匹配。结果显示ECT组出院后1年内全因死亡率较低(校正风险比0.61,95%CI 0.56–0.66),自杀死亡1年生存分析无组间差异,但ECT后最初数月自杀风险显著较低且随时间减弱。
要点
- 老年精神科住院患者接受ECT与出院后1年全因死亡率降低相关。
- ECT后1个月自杀风险显著降低(HR=0.44),保护效应随时间的推移减弱。
- 1年自杀死亡生存分析未显示组间差异。
核心结论
- 在这项观察性研究中,ECT与较低的1年全因死亡率相关,并对自杀风险有短暂的保护效应。
- 研究结果支持对短期自杀风险高的心境障碍住院患者更多考虑ECT。
研究设计与样本
- 观察性研究,纳入65岁及以上接受医保的精神科住院患者。
- 接受ECT的患者与对照组按1:3比例精确匹配,匹配变量包括年龄、性别、主要住院诊断、过去一年精神科住院史、过去一年自杀未遂史和Elixhauser合并症指数。
- 采用Cox比例风险模型,校正种族、住院年份、城乡 continuum 代码、指数住院年份、邮编中位收入和所有匹配协变量,估计风险比及95%置信区间。
- 分析共纳入ECT组10,460例和对照组31,160例(总N=41,620;女性65.4%;平均年龄74.7岁,SD=7.09)。
主要发现
- 与对照组相比,接受ECT的患者出院后1年内全因死亡率较低(校正风险比=0.61,95%CI=0.56, 0.66)。
- 自杀死亡1年生存分析未显示组间差异。
- ECT后最初数月自杀风险显著较低:1个月风险比=0.44(95%CI=0.21, 0.91),2个月风险比=0.52(95%CI=0.29, 0.92),3个月风险比=0.56(95%CI=0.37, 0.92)。
- 自杀风险关联随时间减弱:6个月风险比=0.87(95%CI=0.59, 1.28),12个月风险比=0.92(95%CI=0.68, 1.25)。
关键数值与推荐
- 全因死亡率1年校正风险比=0.61(95%CI=0.56, 0.66),ECT组低于对照组。
- 自杀死亡1个月风险比=0.44(95%CI=0.21, 0.91),2个月风险比=0.52(95%CI=0.29, 0.92),3个月风险比=0.56(95%CI=0.37, 0.92)。
- 自杀死亡6个月风险比=0.87(95%CI=0.59, 1.28),12个月风险比=0.92(95%CI=0.68, 1.25)。
临床怎么用
- 对于65岁及以上精神科住院患者,尤其是心境障碍且短期自杀风险高者,可更多考虑ECT。
- ECT对自杀风险的保护效应主要在治疗后最初数月,临床应在此期间加强监测和随访。
局限性
- 原文未报告局限性内容。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: This observational study examined the effects of electroconvulsive therapy (ECT) on suicide and all-cause mortality risk in older psychiatric patients. METHODS: Participants were Medicare-insured psychiatric inpatients age 65 or older. Patients receiving ECT were exact-matched to control subjects (in a 1:3 ratio) on age, gender, principal hospital diagnosis, past-year psychiatric hospitalizations, past-year suicide attempts, and Elixhauser comorbidity index. Cox proportional hazard models were risk-adjusted for race, year of hospitalization, rural-urban continuum code, year of index hospitalization, median income of zip code, and all matched covariates to estimate hazard ratios with 95% confidence intervals. RESULTS: A total of 10,460 patients in the ECT group and 31,160 in the control group were included in the analyses (total N=41,620; 65.4% female; mean age, 74.7 years [SD=7.09]). Compared with the control group, patients receiving ECT had lower all-cause mortality for up to 1 year following hospital discharge (adjusted hazard ratio=0.61, 95% CI=0.56, 0.66). For death by suicide, 1-year survival analysis showed no group difference. A significant association was observed with suicide in the first months following ECT, but this pattern waned over time (1 month: hazard ratio=0.44, 95% CI=0.21, 0.91; 2 months: hazard ratio=0.52, 95% CI=0.29, 0.92; 3 months: hazard ratio=0.56, 95% CI=0.37, 0.92; 6 months: 0.87, 95% CI=0.59, 1.28; 12 months: 0.92, 95% CI=0.68, 1.25). CONCLUSIONS: In this observational study, ECT was associated with lower 1-year all-cause mortality and with short-lived protective effects on suicide risk. These findings support greater consideration of ECT for inpatients with mood disorders at short-term risk of suicide.
引用
- Rhee TG, Sint K, Olfson M, et al. Association of ECT With Risks of All-Cause Mortality and Suicide in Older Medicare Patients. Am J Psychiatry. 2021. PMID: 34503341. doi:10.1176/appi.ajp.2021.21040351
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。